Collaborative aims to accelerate immunotherapy development for pediatric cancers

October 18, 2018

A new collaborative project, CureWorks, lead by healthcare experts across the United States, aims to accelerate the development of immunotherapy treatments for pediatric cancer.

Michael Jensen, MD, one of the directors at his initiative, states the primary components of this project consist of expanding multi-site clinical trials, creating a central facility for reprogramming immune cells to fight cancer, as well as developing a network of participating hospitals to share resources on the use of CAR T-cell therapy.

Read More

New Treatments and Research

Leave a Comment

Your email address will not be published. Required fields are marked *

Previous reading
Researchers find a ‘critical need’ for whole genome sequencing of young cancer patients
Next reading
New research findings could give pediatric brain tumors a one-two punch